Chemoinformaics analysis of Benzyl 2-methoxybenzoate
| Molecular Weight | 242.274 | nRot | 4 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 13 |
| Exact Molecular Weight | 242.094 | nRing | 2 |
| Solubility: LogS | -3.521 | nHRing | 0 |
| Solubility: LogP | 3.174 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 36.7911 |
| nHD | 0 | BPOL | 18.3849 |
| QED | 0.773 |
| Synth | 1.375 |
| Natural Product Likeliness | -0.528 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.053 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.572 |
| MDCK | 0.0000311 |
| BBB | 0.345 |
| PPB | 0.964688 |
| VDSS | 0.951 |
| FU | 0.0364088 |
| CYP1A2-inh | 0.984 |
| CYP1A2-sub | 0.843 |
| CYP2c19-inh | 0.973 |
| CYP2c19-sub | 0.141 |
| CYP2c9-inh | 0.832 |
| CYP2c9-sub | 0.435 |
| CYP2d6-inh | 0.284 |
| CYP2d6-sub | 0.357 |
| CYP3a4-inh | 0.235 |
| CYP3a4-sub | 0.363 |
| CL | 11.958 |
| T12 | 0.793 |
| hERG | 0.166 |
| Ames | 0.04 |
| ROA | 0.007 |
| SkinSen | 0.452 |
| Carcinogencity | 0.612 |
| EI | 0.974 |
| Respiratory | 0.035 |
| NR-Aromatase | 0.021 |
| Antiviral | No |
| Prediction | 0.691181 |